Dexmedetomidine Depresses Neuronal Activity in the Subthalamic Nucleus During Deep Brain Stimulation Electrode Implantation Surgery

Overview

Journal BJA Open

Specialty Anesthesiology

Date 2023 Aug 17

PMID 37588575

Authors

Corey Amlong

Deborah Rusy

Robert D Sanders

Wendell Lake

Aeyal Raz

Affiliations

Soon will be listed here.

Abstract

Background: Micro-electrode recordings are often necessary during electrode implantation for deep brain stimulation of the subthalamic nucleus. Dexmedetomidine may be a useful sedative for these procedures, but there is limited information regarding its effect on neural activity in the subthalamic nucleus and on micro-electrode recording quality.

Methods: We recorded neural activity in five patients undergoing deep brain stimulation implantation to the subthalamic nucleus. Activity was recorded after subthalamic nucleus identification while patients received dexmedetomidine sedation (loading - 1 μg kg over 10-15 min, maintenance - 0.7 μg kg h). We compared the root-mean square (RMS) and beta band (13-30 Hz) oscillation power of multi-unit activity recorded by microelectrode before, during and after recovery from dexmedetomidine sedation. RMS was normalised to values recorded in the white matter.

Results: Multi-unit activity decreased during sedation in all five patients. Mean normalised RMS decreased from 2.8 (1.5) to 1.6 (1.1) during sedation (43% drop, p = 0.056). Beta band power dropped by 48.4%, but this was not significant (p = 0.15). Normalised RMS values failed to return to baseline levels during the time allocated for the study (30 min).

Conclusions: In this small sample, we demonstrate that dexmedetomidine decreases neuronal firing in the subthalamic nucleus as expressed in the RMS of the multi-unit activity. As multi-unit activity is a factor in determining the subthalamic nucleus borders during micro-electrode recordings, dexmedetomidine should be used with caution for sedation during these procedures.

Clinical Trial Number: NCT01721460.

References

Rezai A, Kopell B, Gross R, Vitek J, Sharan A, Limousin P . Deep brain stimulation for Parkinson's disease: surgical issues. Mov Disord. 2006; 21 Suppl 14:S197-218. DOI: 10.1002/mds.20956. View

Kalenka A, Schwarz A . Anaesthesia and Parkinson's disease: how to manage with new therapies?. Curr Opin Anaesthesiol. 2009; 22(3):419-424. DOI: 10.1097/ACO.0b013e32832a4b31. View

Venkatraghavan L, Manninen P, Mak P, Lukitto K, Hodaie M, Lozano A . Anesthesia for functional neurosurgery: review of complications. J Neurosurg Anesthesiol. 2005; 18(1):64-7. DOI: 10.1097/01.ana.0000181285.71597.e8. View

Walter B, Vitek J . Surgical treatment for Parkinson's disease. Lancet Neurol. 2004; 3(12):719-28. DOI: 10.1016/S1474-4422(04)00934-2. View

Hippard H, Watcha M, Stocco A, Curry D . Preservation of microelectrode recordings with non-GABAergic drugs during deep brain stimulator placement in children. J Neurosurg Pediatr. 2014; 14(3):279-86. DOI: 10.3171/2014.5.PEDS13103. View

Elias W, Durieux M, Huss D, Frysinger R . Dexmedetomidine and arousal affect subthalamic neurons. Mov Disord. 2008; 23(9):1317-20. DOI: 10.1002/mds.22080. View

Chernik D, Gillings D, Laine H, Hendler J, Silver J, Davidson A . Validity and reliability of the Observer's Assessment of Alertness/Sedation Scale: study with intravenous midazolam. J Clin Psychopharmacol. 1990; 10(4):244-51. View

Mahon P, Greene B, Greene C, Boylan G, Shorten G . Behaviour of spectral entropy, spectral edge frequency 90%, and alpha and beta power parameters during low-dose propofol infusion. Br J Anaesth. 2008; 101(2):213-21. DOI: 10.1093/bja/aen161. View

Martinez-Simon A, Valencia M, Cacho-Asenjo E, Honorato-Cia C, Nunez-Cordoba J, Manzanilla O . Effects of dexmedetomidine on subthalamic local field potentials in Parkinson's disease. Br J Anaesth. 2021; 127(2):245-253. PMC: 8362272. DOI: 10.1016/j.bja.2021.01.036. View

10.

Bos M, de Korte-de Boer D, Sanchez A, Duits A, Ackermans L, Temel Y . Impact of Procedural Sedation on the Clinical Outcome of Microelectrode Recording Guided Deep Brain Stimulation in Patients with Parkinson's Disease. J Clin Med. 2021; 10(8). PMC: 8068017. DOI: 10.3390/jcm10081557. View

11.

Weerink M, Struys M, Hannivoort L, Barends C, Absalom A, Colin P . Clinical Pharmacokinetics and Pharmacodynamics of Dexmedetomidine. Clin Pharmacokinet. 2017; 56(8):893-913. PMC: 5511603. DOI: 10.1007/s40262-017-0507-7. View

12.

Hertel F, Zuchner M, Weimar I, Gemmar P, Noll B, Bettag M . Implantation of electrodes for deep brain stimulation of the subthalamic nucleus in advanced Parkinson's disease with the aid of intraoperative microrecording under general anesthesia. Neurosurgery. 2006; 59(5):E1138. DOI: 10.1227/01.NEU.0000245603.77075.55. View

13.

Paris A, Tonner P . Dexmedetomidine in anaesthesia. Curr Opin Anaesthesiol. 2006; 18(4):412-8. DOI: 10.1097/01.aco.0000174958.05383.d5. View

14.

Hamid N, Mitchell R, Mocroft P, Westby G, Milner J, Pall H . Targeting the subthalamic nucleus for deep brain stimulation: technical approach and fusion of pre- and postoperative MR images to define accuracy of lead placement. J Neurol Neurosurg Psychiatry. 2005; 76(3):409-14. PMC: 1739553. DOI: 10.1136/jnnp.2003.032029. View

15.

Bos M, Sanchez A, Bancone R, Temel Y, de Greef B, Absalom A . Influence of Anesthesia and Clinical Variables on the Firing Rate, Coefficient of Variation and Multi-Unit Activity of the Subthalamic Nucleus in Patients with Parkinson's Disease. J Clin Med. 2020; 9(4). PMC: 7230272. DOI: 10.3390/jcm9041229. View

16.

Moran A, Bar-Gad I, Bergman H, Israel Z . Real-time refinement of subthalamic nucleus targeting using Bayesian decision-making on the root mean square measure. Mov Disord. 2006; 21(9):1425-31. DOI: 10.1002/mds.20995. View

17.

Moro E, Lozano A, Pollak P, Agid Y, Rehncrona S, Volkmann J . Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease. Mov Disord. 2010; 25(5):578-86. DOI: 10.1002/mds.22735. View

18.

Krishna V, Elias G, Sammartino F, Basha D, King N, Fasano A . The effect of dexmedetomidine on the firing properties of STN neurons in Parkinson's disease. Eur J Neurosci. 2015; 42(4):2070-7. DOI: 10.1111/ejn.13004. View

19.

Jain V, Chaturvedi A, Pandia M, Bithal P . Effect of dexmedetomidine on recovery profile of patients undergoing anterior cervical discectomy and fusion. J Anaesthesiol Clin Pharmacol. 2019; 35(1):92-98. PMC: 6495628. DOI: 10.4103/joacp.JOACP_5_18. View

20.

Zaidel A, Spivak A, Shpigelman L, Bergman H, Israel Z . Delimiting subterritories of the human subthalamic nucleus by means of microelectrode recordings and a Hidden Markov Model. Mov Disord. 2009; 24(12):1785-93. DOI: 10.1002/mds.22674. View